Projen is committed to the ongoing development of its staff and fully supports apprenticeship programmes. Managing director Martin Seabrook said: ‘We are a growing company and having enthusiastic people with the right skills is central to our future success. That is why Projen is committed to the continued investment in the development of talent and the earlier we can catch them the better.’
Projen takes on new apprentice
Demonstrates continued investment in people
You may also like
Manufacturing
AdvanCell establishes US headquarters and manufacturing hub in Greater Boston
Radiopharmaceutical developer AdvanCell has expanded its US footprint with a new global headquarters and planned manufacturing facility in Massachusetts, supporting the development and future commercialisation of its lead-212 targeted alpha therapy pipeline
Hi Tech Manufacturing
Lonza and Antharis Therapeutics ink licensing deal for dual-payload ADCs targeting GI cancers
Antharis gains rights to Lonza's clinically validated dual-payload technology, combining it with proprietary antibody engineering to advance a lead ADC programme entering clinical trials for gastrointestinal cancers
Training & Education
Length vs weight in medicated implant quality control
In medicated implant manufacturing, quality control must do more than confirm dimensional conformity. It must help protect the integrity of the delivered unit. This raises a practical technical question: when assessing implant quality, which physical attribute is the more defensible primary control for dose integrity, implant length or implant weight?
Hi Tech Manufacturing
Cirena licenses Agilent long RNA purification technology for high-purity genome editing workflows
Cirena has licensed Agilent Technologies' long RNA purification technology to support scalable production of high-purity 100-300 nt RNA constructs for CRISPR, functional genomics and other advanced research applications